Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Drug Information » FDA Approved Drugs » 1998
Medical Areas: Endocrinology | Family Medicine

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Glyburide Tablets

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Mylan Laboratories
Approval Status: Approved July 1998.
Treatment Area: Diabetes Mellitus

General Information

Glyburide tablets in both 1.5 and 3mg strengths have recently been approved to be used as an adjunct to diet to lower the blood glucose level in patients with non-insulin dependent Diabetes Mellitus (Type II), whose Hyperglycemia cannot be controlled by diet alone.